Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 158

1.

Elimination of falsely reactive results in a commercially-available West Nile virus IgM capture enzyme-linked immunosorbent assay by heterophilic antibody blocking reagents.

Prince HE, Lapé-Nixon M, Givens TS, Bradshaw T, Nowicki MJ.

J Immunol Methods. 2017 May;444:24-28. doi: 10.1016/j.jim.2017.02.007. Epub 2017 Feb 16.

PMID:
28216236
2.

Evaluation of Two Enzyme-Linked Immunosorbent Assay Kits for Chikungunya Virus IgM Using Samples from Deceased Organ and Tissue Donors.

Prince HE, Altrich ML, Nowicki MJ.

Clin Vaccine Immunol. 2016 Oct 4;23(10):825-830. Print 2016 Oct.

3.

Evaluation of Commercial Assays for Single-Point Diagnosis of Pertussis in the US.

Pawloski LC, Plikaytis BD, Martin MD, Martin SW, Prince HE, Lapé-Nixon M, Tondella ML.

J Pediatric Infect Dis Soc. 2017 Sep 1;6(3):e15-e21. doi: 10.1093/jpids/piw035.

PMID:
27451419
4.

Evaluation of a multiplex bead immunoassay for determination of immune status to varicella-zoster virus in medical center students and employees.

Loeffelholz MJ, Prince HE.

Clin Vaccine Immunol. 2015 Mar;22(3):351-3. doi: 10.1128/CVI.00561-14. Epub 2015 Jan 14.

5.

Chikungunya virus RNA and antibody testing at a National Reference Laboratory since the emergence of Chikungunya virus in the Americas.

Prince HE, Seaton BL, Matud JL, Batterman HJ.

Clin Vaccine Immunol. 2015 Mar;22(3):291-7. doi: 10.1128/CVI.00720-14. Epub 2014 Dec 24.

6.

Chikungunya virus infections among travelers-United States, 2010-2013.

Lindsey NP, Prince HE, Kosoy O, Laven J, Messenger S, Staples JE, Fischer M.

Am J Trop Med Hyg. 2015 Jan;92(1):82-7. doi: 10.4269/ajtmh.14-0442. Epub 2014 Oct 27.

7.

Role of cytomegalovirus (CMV) IgG avidity testing in diagnosing primary CMV infection during pregnancy.

Prince HE, Lapé-Nixon M.

Clin Vaccine Immunol. 2014 Oct;21(10):1377-84. doi: 10.1128/CVI.00487-14. Epub 2014 Aug 27. Review.

8.

Multilaboratory assessment of threshold versus fold-change algorithms for minimizing analytical variability in multiplexed pneumococcal IgG measurements.

Daly TM, Pickering JW, Zhang X, Prince HE, Hill HR.

Clin Vaccine Immunol. 2014 Jul;21(7):982-8. doi: 10.1128/CVI.00235-14. Epub 2014 May 7.

9.

Potential impact of different cytomegalovirus (CMV) IgM assays on an algorithm requiring IgM reactivity as a criterion for measuring CMV IgG avidity.

Prince HE, Lapé-Nixon M, Brenner A, Pitstick N, Couturier MR.

Clin Vaccine Immunol. 2014 Jun;21(6):813-6. doi: 10.1128/CVI.00106-14. Epub 2014 Mar 26.

10.

Performance of a cytomegalovirus IgG enzyme immunoassay kit modified to measure avidity.

Prince HE, Lapé-Nixon M, Novak-Weekley SM.

Clin Vaccine Immunol. 2014 Jun;21(6):808-12. doi: 10.1128/CVI.00105-14. Epub 2014 Mar 26.

11.

Detection of the dengue virus NS1 antigen using an enzyme immunoassay.

Anderson NW, Jespersen DJ, Rollins L, Seaton B, Prince HE, Theel ES.

Diagn Microbiol Infect Dis. 2014 Jun;79(2):194-7. doi: 10.1016/j.diagmicrobio.2014.02.001. Epub 2014 Feb 22.

PMID:
24657172
12.

Characteristics of antibody responses in West Nile virus-seropositive blood donors.

Carson PJ, Prince HE, Biggerstaff BJ, Lanciotti R, Tobler LH, Busch M.

J Clin Microbiol. 2014 Jan;52(1):57-60. doi: 10.1128/JCM.01932-13. Epub 2013 Oct 16.

13.

Impact of the Yosemite hantavirus outbreak on hantavirus antibody testing at a national reference laboratory.

Prince HE, Lieberman JM.

Clin Vaccine Immunol. 2013 Aug;20(8):1213-6. doi: 10.1128/CVI.00326-13. Epub 2013 Jun 5.

14.

Reactivity of human IgM binding murine monoclonal 6B6C1 (IgG2a) with other murine monoclonal IgG antibodies.

Prince HE, Yeh C.

J Clin Lab Anal. 2013 Jan;27(1):27-30. doi: 10.1002/jcla.21557. Epub 2013 Jan 4.

PMID:
23292827
15.

Neuroinvasive disease and West Nile virus infection, North Dakota, USA, 1999-2008.

Carson PJ, Borchardt SM, Custer B, Prince HE, Dunn-Williams J, Winkelman V, Tobler L, Biggerstaff BJ, Lanciotti R, Petersen LR, Busch MP.

Emerg Infect Dis. 2012 Apr;18(4):684-6. doi: 10.3201/eid1804.111313.

16.

Age-related differences in patterns of increased Bordetella pertussis antibodies.

Prince HE, Lieberman JM, Cherry JD.

Clin Vaccine Immunol. 2012 Apr;19(4):545-50. doi: 10.1128/CVI.05725-11. Epub 2012 Feb 22.

17.
18.

Estimation of dengue virus IgM persistence using regression analysis.

Prince HE, Matud JL.

Clin Vaccine Immunol. 2011 Dec;18(12):2183-5. doi: 10.1128/CVI.05425-11. Epub 2011 Oct 26.

19.

Utility of IgM/IgG ratio and IgG avidity for distinguishing primary and secondary dengue virus infections using sera collected more than 30 days after disease onset.

Prince HE, Yeh C, Lapé-Nixon M.

Clin Vaccine Immunol. 2011 Nov;18(11):1951-6. doi: 10.1128/CVI.05278-11. Epub 2011 Aug 31.

20.

Dengue virus immunoglobulin M detection in a reference laboratory setting during the 2010 dengue virus outbreak on Caribbean islands.

Prince HE, Matud JL, Lieberman JM.

Clin Vaccine Immunol. 2011 Jul;18(7):1104-7. doi: 10.1128/CVI.05096-11. Epub 2011 May 25.

21.

Chikungunya fever in the United States: a fifteen year review of cases.

Gibney KB, Fischer M, Prince HE, Kramer LD, St George K, Kosoy OL, Laven JJ, Staples JE.

Clin Infect Dis. 2011 Mar 1;52(5):e121-6. doi: 10.1093/cid/ciq214. Epub 2011 Jan 17.

PMID:
21242326
22.
23.

Tregs control the development of symptomatic West Nile virus infection in humans and mice.

Lanteri MC, O'Brien KM, Purtha WE, Cameron MJ, Lund JM, Owen RE, Heitman JW, Custer B, Hirschkorn DF, Tobler LH, Kiely N, Prince HE, Ndhlovu LC, Nixon DF, Kamel HT, Kelvin DJ, Busch MP, Rudensky AY, Diamond MS, Norris PJ.

J Clin Invest. 2009 Nov;119(11):3266-77. doi: 10.1172/JCI39387. Epub 2009 Oct 12.

24.

Performance characteristics of the Euroimmun enzyme-linked immunosorbent assay kits for Brucella IgG and IgM.

Prince HE, Lopez J, Yeh C, Tablante J, Morgan J, Kaneko B, Duffey P.

Diagn Microbiol Infect Dis. 2009 Oct;65(2):99-102. doi: 10.1016/j.diagmicrobio.2009.06.002.

PMID:
19748418
25.

Evaluation of a multiplex bead-based screening assay for detection of binding antibodies to interferon-beta.

Lapé Nixon M, Matud J, Yeh C, Prince HE.

J Neuroimmunol. 2009 May 29;210(1-2):104-7. doi: 10.1016/j.jneuroim.2009.03.009. Epub 2009 Apr 3.

PMID:
19345423
26.

Frequency of missed cases of probable acute West Nile virus (WNV) infection when testing for WNV RNA alone or WNV immunoglobulin M alone.

Prince HE, Calma J, Pham T, Seaton BL.

Clin Vaccine Immunol. 2009 Apr;16(4):587-8. doi: 10.1128/CVI.00462-08. Epub 2009 Feb 18.

27.

Virus and antibody dynamics in acute west nile virus infection.

Busch MP, Kleinman SH, Tobler LH, Kamel HT, Norris PJ, Walsh I, Matud JL, Prince HE, Lanciotti RS, Wright DJ, Linnen JM, Caglioti S.

J Infect Dis. 2008 Oct 1;198(7):984-93. doi: 10.1086/591467.

PMID:
18729783
28.

Interferon and interferon-induced chemokine expression is associated with control of acute viremia in West Nile virus-infected blood donors.

Tobler LH, Cameron MJ, Lanteri MC, Prince HE, Danesh A, Persad D, Lanciotti RS, Norris PJ, Kelvin DJ, Busch MP.

J Infect Dis. 2008 Oct 1;198(7):979-83. doi: 10.1086/591466. Erratum in: J Infect Dis. 2008 Nov 15;198(10):1575.

PMID:
18729779
29.

Evaluation of enzyme-linked immunosorbent assays for detecting circulating antibodies to Candida albicans.

Prince HE, Yeh C, Alem N, Asalkhou M, Hamedi N, Alem N, Alem M.

J Clin Lab Anal. 2008;22(4):234-8. doi: 10.1002/jcla.20242.

PMID:
18623122
30.

Development of a more efficient algorithm for identifying false-positive reactivity results in a dengue virus immunoglobulin M screening assay.

Prince HE, Yeh C, Lapé-Nixon M.

Clin Vaccine Immunol. 2008 Aug;15(8):1304-6. doi: 10.1128/CVI.00157-08. Epub 2008 Jun 18.

31.

Persistence of antibodies to West Nile virus nonstructural protein 5.

Prince HE, Lapé-Nixon M, Yeh C, Tobler LH, Busch MP.

J Clin Virol. 2008 Sep;43(1):102-6. doi: 10.1016/j.jcv.2008.03.025. Epub 2008 May 8.

PMID:
18467165
32.

Identification of interferon-beta antibodies in a reference laboratory setting: findings for 1144 consecutive sera.

Prince HE, Lapé-Nixon M, Audette C, Van Horn K.

J Neuroimmunol. 2007 Oct;190(1-2):165-9. Epub 2007 Sep 21.

PMID:
17889376
33.

Persistence of West Nile virus-specific antibodies in viremic blood donors.

Prince HE, Tobler LH, Yeh C, Gefter N, Custer B, Busch MP.

Clin Vaccine Immunol. 2007 Sep;14(9):1228-30. Epub 2007 Jul 25.

34.

Further comparisons of assays for detecting MAG IgM autoantibodies.

Jaskowski TD, Prince HE, Greer RW, Litwin CM, Hill HR.

J Neuroimmunol. 2007 Jul;187(1-2):175-8. Epub 2007 May 29.

PMID:
17537521
36.
37.

West Nile virus infections projected from blood donor screening data, United States, 2003.

Busch MP, Wright DJ, Custer B, Tobler LH, Stramer SL, Kleinman SH, Prince HE, Bianco C, Foster G, Petersen LR, Nemo G, Glynn SA.

Emerg Infect Dis. 2006 Mar;12(3):395-402.

38.

Evaluation of a tetraplex microsphere assay for Bordetella pertussis antibodies.

Prince HE, Lapé-Nixon M, Matud J.

Clin Vaccine Immunol. 2006 Feb;13(2):266-70.

40.

Biomarkers for diagnosing and monitoring autoimmune diseases.

Prince HE.

Biomarkers. 2005 Nov;10 Suppl 1:S44-9. Review.

PMID:
16298911
41.

Utilization of follow-up specimens from viremic blood donors to assess the value of west nile virus immunoglobulin G avidity as an indicator of recent infection.

Prince HE, Lapé-Nixon M, Busch MP, Tobler LH, Foster GA, Stramer SL.

Clin Diagn Lab Immunol. 2005 Sep;12(9):1123-6.

42.

Development and persistence of West Nile virus-specific immunoglobulin M (IgM), IgA, and IgG in viremic blood donors.

Prince HE, Tobler LH, Lapé-Nixon M, Foster GA, Stramer SL, Busch MP.

J Clin Microbiol. 2005 Sep;43(9):4316-20.

43.

Detection of West Nile virus RNA and antibody in frozen plasma components from a voluntary market withdrawal during the 2002 peak epidemic.

Tobler LH, Bianco C, Glynn SA, Schreiber GB, Dille BJ, Prince HE, Lanciotti RS, Linnen JM, Gallarda J, Shyamala V, Smith D, Kleinman SH, Busch MP; NHLBI Retrovirus Epidemiology Study (REDS).

Transfusion. 2005 Apr;45(4):480-6.

PMID:
15819666
44.

Evaluation of a West Nile virus immunoglobulin A capture enzyme-linked immunosorbent assay.

Prince HE, Lapé-Nixon M.

Clin Diagn Lab Immunol. 2005 Jan;12(1):231-3.

46.

Supplemental Content

Loading ...
Support Center